Chemomab Therapeutics Ltd - ADR (CMMB) has fallen Wednesday morning, with the stock declining -9.17% in pre-market trading to 2.08.
CMMB's short-term technical score of 77 indicates that the stock has traded more bullishly over the last month than 77% of stocks on the market. In the Biotechnology industry, which ranks 121 out of 146 industries, Chemomab Therapeutics Ltd - ADR ranks higher than 83% of stocks.
Chemomab Therapeutics Ltd - ADR has risen 1.33% over the past month, closing at $2.32 on January 25. During this period of time, the stock fell as low as $1.96 and as high as $2.70. CMMB has an average analyst recommendation of Strong Buy. The company has an average price target of $16.33.
CMMB has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on CMMB!
Chemomab Therapeutics Ltd - ADR has a Long-Term Technical rank of 44. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 56% of the market scoring higher. In the Biotechnology industry which is number 129 by this metric, CMMB ranks better than 129% of stocks.
